<DOC>
	<DOC>NCT02517580</DOC>
	<brief_summary>This study is a single arm, single center clinical trial that aims to evaluate the effect of 8 weeks of vitamin K2 replacement (360 mcg/day) on the progression of arterial stiffness in stable renal transplant patients.</brief_summary>
	<brief_title>Vitamin K2 Supplementation and Arterial Stiffness in the Renal Transplant Population (The KING Trial)</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<criteria>Functional renal graft Stable renal function for at least 3 months prior to enrollment History of thrombotic events Diagnosed coagulopathy Cardiovascular event in the past month prior to enrollment Current or planned pregnancy Lactation Soy allergy Concomitant or recent (past 6 months) use of supplements that contain vitamin K Warfarin treatment Known intestinal malabsorption or hypomotility syndromes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>